PH Impedance and high-resolution manometry in laryngopharyngeal reflux disease high-dose proton pump inhibitor failures

Laryngoscope

Volumn 122, Issue 11, 2012, Pages 2473-2481

  Carroll, Thomas L ^a   Fedore, Lauren W ^b   Aldahlawi, Moataz M ^a  

^a TUFTS MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

esophageal manometry; high resolution esophageal manometry; impedance testing; laryngopharyngeal reflux; laryngopharyngeal reflux disease; Level of Evidence: 4; Multichannel intraluminal pH impedance; pH impedance testing; proton pump inhibitor

Indexed keywords

OMEPRAZOLE; PROTON PUMP INHIBITOR;

ADULT; ARTICLE; BREAK THROUGH ACID REFLUX; CATHETER; CLINICAL ARTICLE; DIGESTIVE SYSTEM FUNCTION DISORDER; DRUG MEGADOSE; DRUG TREATMENT FAILURE; FEMALE; HIGH RESOLUTION ESOPHAGEAL MANOMETRY; HUMAN; LARYNGOPHARYNGEAL REFLUX; MALE; MANOMETRY; MULTICHANNEL INTRALUMINAL PH IMPEDANCE; NONACID REFLUX; PH; PRIORITY JOURNAL;

ADULT; AGED; ANALYSIS OF VARIANCE; ESOPHAGEAL PH MONITORING; FEMALE; HUMANS; LARYNGOPHARYNGEAL REFLUX; MALE; MANOMETRY; MIDDLE AGED; OMEPRAZOLE; PROTON PUMP INHIBITORS; RETROSPECTIVE STUDIES; TREATMENT FAILURE;

EID: 84868000727     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.23518     Document Type: Article

References (34)

1. Kaufman JA, Aviv JE, Casiano RR, et al. Laryngopharyngeal reflux: position statement of the committee on speech, voice, and swallowing disorders of the American Academy of Otolaryngology-Head and Neck Surgery. Otolaryngol Head Neck Surg 2002; 127: 32-35.
2. Khan A, Cho I, Traube M,. People with throat symptoms on acid suppressive therapy: Do they have reflux? Dig Dis Sci 2010; 55: 346-350.
3. Samuels TL, Johnston N,. Pepsin as a marker of extraesophageal reflux. Ann Otol Rhinol Laryngol 2010; 119: 203-208.
4. Tutuian R, Castell DO,. Use of multichannel intraluminal impedance to document proximal esophageal and pharyngeal nonacidic reflux episodes. Am J Med 2003; 115: 119S-123S.
5. Ayazi S, Hagen JA, Zehetner J, et al. The Value of high-resolution manometry in the assessment of the resting characteristics of the lower esophageal sphincter. J Gastrointest Surg 2009; 13: 2113-2120.
6. Koufman JA,. The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope 1991; 101:(4 pt 2 suppl 53): 1-78.
7. Becker V, Bajbouj M, Waller K, et al. Clinical trial: persistent gastro-oesophageal reflux symptoms despite standard therapy with proton pump inhibitors-a follow-up study of intraluminal-impedance guided therapy. Aliment Pharmacol Ther 2007; 26: 1355-1360.
8. Sifrim D, Castell D, Dent J, et al. Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non- acid, and gas reflux. Gut 2004; 53: 1024-1031.
9. Meyer TK, Olsen E, Merati A,. Contemporary diagnostic and management techniques for extraesophageal reflux disease. Curr Opin Otolaryngol Head Neck Surg 2004; 12: 519-524.
10. Ford CN,. Evaluation and management of laryngopharyngeal reflux. JAMA 2005; 294: 1534-1540.
11. Perry KA, Enestvedt CK, Lorenzo CS, et al. The integrity of esophagogastric junction anatomy in patients with isolated laryngopharyngeal reflux symptoms. J Gastrointest Surg 2008; 12: 1880-1887.
12. Yang YX, Lewis JD, Epstein S, et al. Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA 2006; 296: 2947-2953.
13. Altman KW, Radosevich JA,. Unexpected consequences of proton pump inhibitor use. Otolaryngol Head Neck Surg 2009; 141: 564-566.
14. Fass R,. Proton-pump inhibitor therapy in patients with gastro-oesophageal reflux disease putative mechanisms of failure. Drugs 2007; 67: 1521-1530.
15. Iwakiri K, Kawami N, Sano H, et al. Acid and non-acid reflux in Japanese patients with non-erosive reflux disease with persistent reflux symptoms, despite taking a double-dose of proton pump inhibitor: a study using combined pH-impedance monitoring. J Gastroenterol 2009; 44: 708-712.
16. Belafsky PC, Postma GN, Koufman JA,. Validity and reliability of the reflux symptom index (RSI). J Voice 2002; 16: 274-277.
17. Mainie I, Tutuian R, Agrawal A, et al. Combined multichannel intraluminal impedance-pH monitoring to select patients with persistent gastro-oesophageal reflux for laparoscopic Nissen fundoplication. Br J Surg 2006; 93: 1483-1487.
18. Mainie I, Tutuian R, Shay S, et al. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring. Gut 2006; 55: 1398-1402.
19. Aanen MC, Bredenoord AJ, Numans ME, et al. Reproducibility of symptom association analysis in ambulatory reflux monitoring. Am J Gastroenterol 2008; 103: 2200-2208.
20. Vaezi MF, Richter JE, Stasney CR, et al. Treatment of chronic posterior laryngitis with esomeprazole. Laryngoscope 2006; 116: 254-260.
21. Zerbib F, Stoll D,. Management of laryngopharyngeal reflux: an unmet medical need. Neurogastroenterol Motil 2010; 22: 109-112.
22. Hoppo T, Sanz A, Nason KS, et al. How much pharyngeal exposure is "normal?" Normative data for laryngopharyngeal reflux events using hypopharyngeal multichannel intraluminal impedance (HMII). J Gastrointest Surg 2012; 16: 16-24; discussion 24-25.
23. del Genio G, Tolone S, del Genio F, et al. Total fundoplication controls acid and nonacid reflux: evaluation by pre- and postoperative 24-h pH-multichannel intraluminal impedance. Surg Endosc 2008; 22: 2518-2523.
24. Catania RA, Kavic SM, Roth JS, et al. Laparoscopic Nissen fundoplication effectively relieves symptoms in patients with laryngopharyngeal reflux. J Gastrointest Surg 2007; 11: 1579-1587.
25. Shay S, Tutuian R, Sifrim D, et al. Twenty-four hour ambulatory simultaneous impedance and pH monitoring: a multicenter report of normal values from 60 healthy volunteers. Am J Gastroenterol 2004; 99: 1037-1043.
26. Misra S,. Can acid (pH) refluxes predict multichannel intraluminal impedance refluxes? A correlation study. J Gastroenterol Hepatol 2010; 25: 817-822.
27. Charbel S, Khandwala F, Vaezi MF,. The role of esophageal pH monitoring in symptomatic patients on PPI therapy. Am J Gastroenterol 2005; 100: 283-289.
28. Karamanolis G, Vanuytsel T, Sifrim D, et al. Yield of 24-hour esophageal pH and Bilitec monitoring in patients with persisting symptoms on PPI therapy. Dig Dis Sci 2008; 53: 2387-2393.
29. Oelschlager BK, Quiroga E, Isch JA, et al. Gastroesophageal and pharyngeal reflux detection using impedance and 24 h pH monitoring in asymptomatic subjects: defining the normal environment. J Gastrointest Surg 2006; 10: 54-62.
30. Roth D, Ferguson BJ,. Vocal allergy: recent advances in understanding allergy in dysphonia. Curr Opin Otolaryngol Head Neck Surg 2010; 18: 176-181.
31. Reese CJ, Henderson AH, Belafsky PC,. Postviral vagal neuropathy. Ann Otol Rhinol Laryngol 2009; 118: 247-252.
32. Lee B, Woo P,. Chronic cough as a sign of laryngeal sensory neuropathy: diagnosis and treatment. Ann Otol Rhinol Laryngol 2005; 114: 253-257.
33. Amin MR, Koufman JA,. Vagal neuropathy after upper respiratory infection: a viral etiology? Am J Otolaryngol 2001; 22: 251-256.
34. McGlashan JA, Johnstone LM, Sykes J, et al. The value of liquid alginate suspension (Gaviscon Advance) in the management of laryngopharyngeal reflux. Eur Arch Otorhinolaryngol 2009; 266: 243-251.